Summary
The pharmacokinetics of ginsenosides A1, A2, B2, and C were studied in rabbits and were best described with a one-compartment open model. Ginsenoside C (protopanaxadiol group ginseng saponin) showed a significantly longer half-life, higher plasma protein binding, and lower metabolic and renal clearance than ginsenosides A1, A2, and B2 (protopanaxatriol group ginseng saponins). All ginsenosides except ginsenoside A1 were slowly absorbed after intraperitoneal administration. Ginsenosides were not found in rabbit plasma or urine samples after oral administration. The observed differences in the pharmacokinetics of the ginsenosides may be ascribed to differences in protein binding. Ginsenoside C was more toxic than ginsenoside A2 after intraperitoneal administration to mice. Toxicity was not observed after oral administration of any of the ginsenosides. The genins, panaxadiol and panaxatriol, were more toxic and had larger volumes of distribution than the ginsenosides.
This is a preview of subscription content, access via your institution.
References
Takagi K., Saito H. and Tsuchiya M. (1972): Pharmacological studies ofPanax ginseng root: pharmacological properties of a crude saponin fraction. Jap. J. Pharmacol.,22, 339–346.
Namba T., Yoshizaki M., Tomimori T., Kobashi K., Mitsue K., and Hase J. (1973): Hemolytic and protective activity of ginseng saponins. Chem. Pharm. Bull.,21(2), 459–461.
Kaku T., Miyata T., Urono T., Sako I., and Kinoshita A. (1975): Chemical-pharmacological studies on saponins of Panax ginseng. C.A. Meyer. Arzneim-Forsch.,25(3), 343–347.
Chen S.E, and Staba E.J. (1978): American ginseng I. Large scale isolation of ginsenosides from leaves and stems. Lloydia,41(4), 361–366.
Shibata S. (1974): Some chemical studies on ginseng. Proc. Inst. Ginseng Symp. (Seoul, Korea), 69–76.
Tanaka O. and Yahara S. (1978): Dammarane saponins of leaves ofPanax pseudo-ginseng subsp.himalaicus. Phytochemistry,17, 1353–1358.
Kim J.Y. and Staba E.J. (1974): Plant biochemistry of gin-seng saponins. Proc. Int. Ginseng Symp. (Seoul, Korea), 77–93.
Otsuka H., Morita Y., Ogihara Y., and Shibata S. (1977): The evaluation of ginseng and its congeners by droplet counter-current chromatography (DCC). Planta Medica,32, 9–17.
Liberti L.E., and Marderosian, A.D. (1978): Evaluation of commercial ginseng products. J. Pharm. Sci.,67, 1487–1489.
Bombardelli E., Bonati A., Gabetta B., Martineiii E.M. and Mustich G. (1976): Gas-liquid chromatographic and mass spectrometric investigation on saponins inPanax ginseng extracts. Fitoterapia57(3), 99–106.
Hartley H.O. (1961): The modified Gauss-Newton method for the fitting of nonlinear regression functions by least squares. Technometrics,3, 269–280.
Hartley H.O. and Booker A. (1965): Nonlinear least squares estimation. Ann. Math. Stat.,36, 638–650.
Okita G.T.: In Digitalis, ed. by Fish C. and Surawicz B., Grune & Stratton (New York 1969), pp 13–14.
Doherty J.E. (1973): Digitalis glycosides, pharmacokinetics and their clinical implications. Ann. Intern. Med.,79, 229–238.
Han B.H., Lee E.B., Yoon U.C. and Woo L.K. (1976): Metabolism of dammarane glycosides of Korean ginseng. I. Absorption and excretion of Panax Saponin A. Korean Biochem. J.,9, 21–27.
Han B. and Chang I.M. (1977): Metabolism of dammarane triterpene glycosides of Korean ginseng. I. Absorption, organ distribution and excretion of3H-Panax Saponin A. Korean J. Ginseng Sci.,2(1), 17–33.
Tagagi K. (1974): Pharmacological studies on ginseng. Proc. Int. Ginseng Symp. (Seoul, Korea), 119–127.
Stengel F. and Listabarth H. (1968): Clinical trials of a new geriatric preparation. Ärztliche Praxis,20(4), 130–135.
Trabucchi E. (1969): Toxicological and pharmacological examination of “Geriatric” Pharmaton. Forschungsrap-port, Pharmakol. Inst. Milano,31, 1.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chen, S.E., Sawchuk, R.J. & Staba, E.J. American ginseng. III. Pharmacokinetics of ginsenosides in the rabbit. European Journal of Drug Metabolism and Pharmacokinetics 5, 161–168 (1980). https://doi.org/10.1007/BF03189460
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03189460
Key-words
- Ginseng
- ginsenosides
- pharmacokinetics
- elimination